Estia Health (ASX:EHE) - Cotización, noticias y análisis

Resumen de acción EHE

Estia Health Limited provides residential aged care home services in Australia.

EHE fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	0/6
Financial Health	3/6
Dividends	2/6

Recompensas

Cotiza un 59% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 66.96%

Análisis de riesgos

El dividendo de 5.1% no está bien cubierto por los beneficios

Competidores de Estia Health Limited

Regis Healthcare

ASX:REG

AU$1.2b

Monash IVF Group

ASX:MVF

AU$520.2m

Pacific Smiles Group

ASX:PSQ

AU$304.0m

Ramsay Health Care

ASX:RHC

AU$11.3b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Estia Health
Historical stock prices
Current Share Price	AU$3.08
52 Week High	AU$3.14
52 Week Low	AU$1.93
Beta	0.96
1 Month Change	0.98%
3 Month Change	1.99%
1 Year Change	57.95%
3 Year Change	77.01%
5 Year Change	41.28%
Change since IPO	-35.02%

Noticias y actualizaciones recientes

Recent updates

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

Feb 25

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Nov 04

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Apr 13

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Mar 08

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Feb 21

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Jan 24

Rentabilidad de los accionistas

	EHE	AU Healthcare	Mercado AU
7D	0%	2.6%	1.8%
1Y	57.9%	-21.8%	10.8%

Rentabilidad vs. Industria: EHE superó al sector Australian Healthcare , que obtuvo un rendimiento del -24% el año pasado.

Rentabilidad vs. Mercado: EHE superó al mercado Australian, que obtuvo un rendimiento del 3.9% el año pasado.

Volatilidad de los precios

Is EHE's price volatile compared to industry and market?
EHE volatility
EHE Average Weekly Movement	0.6%
Healthcare Industry Average Movement	5.6%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	16.2%
10% least volatile stocks in AU Market	3.2%

Precio estable de las acciones: EHE no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de EHE (1%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
2005	8,220	Sean Bilton	www.estiahealth.com.au

Resumen de fundamentos de Estia Health Limited

¿Cómo se comparan los beneficios e ingresos de Estia Health con su capitalización de mercado?
Estadísticas fundamentales de EHE
Capitalización bursátil	AU$805.54m
Beneficios(TTM)	-AU$33.90m
Ingresos (TTM)	AU$754.30m

1.1x

Ratio precio-ventas (PS)

-23.8x

Ratio precio-beneficio (PE)

¿Está EHE sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de EHE
Ingresos	AU$754.30m
Coste de los ingresos	AU$584.82m
Beneficio bruto	AU$169.48m
Otros gastos	AU$203.37m
Beneficios	-AU$33.90m

Últimos beneficios comunicados

Jun 30, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	-0.13
Margen bruto	22.47%
Margen de beneficio neto	-4.49%
Ratio deuda/patrimonio	14.0%

¿Cómo se ha desempeñado EHE a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

5.1%

Rentabilidad actual por dividendo

-120%

Ratio de pagos

Resumen de acción EHE

Recompensas

Análisis de riesgos

Competidores de Estia Health Limited

ASX:REG

AU$1.2b

ASX:MVF

AU$520.2m

ASX:PSQ

AU$304.0m

ASX:RHC

AU$11.3b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

Consensus EPS estimates fall by 15%

Price target increased by 12% to AU$2.83

Independent Non-Executive Chairman recently bought AU$52k worth of stock

Consensus EPS estimates fall by 22%, revenue upgraded

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought AU$106k worth of stock

Consensus forecasts updated

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Consensus estimates of losses per share improve by 51%

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Consensus forecasts updated

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

Consensus forecasts updated

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings: EPS misses analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Consensus forecasts updated

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Price target increased to AU$2.15

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Price target raised to AU$1.94

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: AU$1.96

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Is Estia Health (ASX:EHE) Using Too Much Debt?

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares?

New 90-day high: AU$1.63

New 90-day low: AU$1.36

New 90-day low: AU$1.37

Non-Executive Director recently bought AU$101k worth of stock

Price target lowered to AU$1.62

Earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Did Estia Health Limited (ASX:EHE) Insiders Buy Up More Shares?

Is There Now An Opportunity In Estia Health Limited (ASX:EHE)?

Estia Health Limited(ASX:EHE) dropped from S&P/ASX 200 Index